Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_assertion evidence source_evidence_literature NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_assertion SIO_000772 16507781 NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_assertion wasDerivedFrom gad-20150221 NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_assertion wasGeneratedBy ECO_0000203 NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.
- gad-20150221 importedOn "2015-02-21" NP99228.RA-S2myX8ydo9CHeGLTcwXX82pSCXocGxeMcwtDaj4AUA130_provenance.